MapLight Therapeutics, Inc. (MPLT)
13.39
+0.42
(+3.24%)
USD |
NASDAQ |
Sep 01, 16:00
13.39
0.00 (0.00%)
After-Hours: 17:23
MapLight Therapeutics Total Long Term Debt (Quarterly) : 0.755M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.755M |
| March 31, 2026 | 4.671M |
| December 31, 2025 | 4.911M |
| September 30, 2025 | 5.144M |
| June 30, 2025 | 5.372M |
| Date | Value |
|---|---|
| March 31, 2025 | 5.59M |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 5.294M |
| March 31, 2023 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Evommune, Inc. | 7.392M |
| Sarepta Therapeutics, Inc. | 1.046B |
| Cullinan Therapeutics, Inc. | 1.405M |
| Mineralys Therapeutics, Inc. | 97.62M |
| Apogee Therapeutics, Inc. | 103.70M |